bromocriptine has been researched along with 2019 Novel Coronavirus Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kamiyama, T; Mizuno, T; Suzuki, A; Suzuki, M; Takahashi, R | 1 |
| Apramian, A; Kajani, R; Liu, A; Ubhayakar, N; Vega, A; Xu, P | 1 |
| Kataria, S; Khan, E; Kramer, J; Moreno-Escobar, MC; Niaze, F; Peshwe, K; Sriwastava, S; Subedi, R; Tandon, M | 1 |
1 review(s) available for bromocriptine and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Acute transverse myelitis with Dysautonomia following SARS-CoV-2 infection: A case report and review of literature.
Topics: Adult; Anti-Inflammatory Agents; Bromocriptine; COVID-19; Dopamine Agonists; Humans; Male; Methylprednisolone; Myelitis, Transverse; Primary Dysautonomias; SARS-CoV-2; Spinal Cord | 2021 |
2 other study(ies) available for bromocriptine and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Neuroleptic Malignant Syndrome with Adrenal Insufficiency After BNT162b2 COVID-19 Vaccination in a Man Taking Valproate: A Case Report.
Topics: Adrenal Insufficiency; Adrenocorticotropic Hormone; BNT162 Vaccine; Bromocriptine; COVID-19; Dantrolene; Humans; Hydrocortisone; Male; Middle Aged; Neuroleptic Malignant Syndrome; Vaccination; Valproic Acid | 2022 |
Neuroleptic malignant syndrome in a COVID-19 patient.
Topics: Acute Kidney Injury; Antipsychotic Agents; Betacoronavirus; Bromocriptine; C-Reactive Protein; Coronavirus Infections; COVID-19; Dantrolene; Dopamine Agonists; Enzyme Inhibitors; Haloperidol; Humans; Hydroxychloroquine; Intensive Care Units; Leukocytosis; Lymphopenia; Male; Middle Aged; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Pandemics; Pneumonia, Viral; Renal Dialysis; Respiration, Artificial; Rhabdomyolysis; SARS-CoV-2; Schizophrenia | 2020 |